Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis

Journal of the Formosan Medical Association

Volumn 113, Issue 4, 2014, Pages 249-254

  Wang, Chia Chi ^a   Hsieh, Tsung Cheng ^a   Tseng, Tai Chung ^a   Wang, Pin Chao ^a   Hsu, Ching Sheng ^a   Lin, Hans Hsienhong ^a   Wang, Li Yu ^b   Kao, Jia Horng ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Diagnostic accuracy; Hepatic steatosis; Histology; Ultrasonography

Indexed keywords

ADULT; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; HISTOLOGY ACTIVITY INDEX SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISHAK FIBROSIS SCORE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SCORING SYSTEM; SERODIAGNOSIS; AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84897115339     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.07.004     Document Type: Article

References (32)

1. Chitturi S., Farrell G.C., George J. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?. J Gastroenterol Hepatol 2004, 19:368-374.
2. Liu C.J., Jeng Y.M., Chen P.J., Lai M.Y., Yang H.C., Huang W.L., et al. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Antivir Ther 2005, 10:504-515.
3. Williams R. The pervading influence of alcoholic liver disease in hepatology. Alcohol Alcohol 2008, 43:393-397.
4. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
5. Caldwell S.H., Oelsner D.H., Iezzoni J.C., Hespenheide E.E., Battle E.H., Driscoll C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664-669.
6. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
7. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003, 37:917-923.
8. Clark J.M., Diehl A.M. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2002, 2:210-215.
9. Santoliquido A., Di Campli C., Miele L., Gabrieli M.L., Forgione A., Zocco M.A., et al. Hepatic steatosis and vascular disease. Eur Rev Med Pharmacol Sci 2005, 9:269-271.
10. Wang C.C., Lin S.K., Tseng Y.F., Hsu C.S., Tseng T.C., Lin H.H., et al. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009, 24:1411-1416.
11. Targher G., Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240.
12. Brea A., Mosquera D., Martin E., Arizti A., Cordero J.L., Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005, 25:1045-1050.
13. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Zenari L., et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006, 29:1325-1330.
14. Sookoian S., Pirola C.J. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systemic review. J Hepatol 2008, 49:600-607.
15. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., et al. The severity of ultrasound findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715.
16. Fishbein M.H., Miner M., Mogren C., Chalekson J. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastroenterol Nutr 2003, 36:54-61.
17. Maharaj B., Maharaj R.J., Leary W.P., Cooppan R.M., Naran A.D., Pirie D., et al. Sampling Variabilty and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986, 1:523-525.
18. Poynard T., Ratziu V., Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000, 14:543-548.
19. Mathiesen U.L., Franzen L.E., Aselius H., Resjo M., Jacobsson L., Foberg U., et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002, 34:516-522.
20. Mazhar S.M., Shiehmorteza M., Sirlin C.B. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009, 7:135-140.
21. Lupsor M., Badea R. Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy?. Romanian J Gastroenterol 2005, 14:419-425.
22. Fishbein M., Castro F., Cheruku S., Jain S., Webb B., Gleason T., et al. Hepatic MRI for fat quantification: its relationship to fat morphology, diagnosis and ultrasound. J Clin Gastroenterol 2005, 39:619-625.
23. Rumack C.M., Wilson S.R., Charboneau J.W. Diagnostic ultrasound 1998, Mosby, St. Louis, MO, p. 110-112. 2nd ed.
24. Strauss S., Gavish E., Gottlieb P., Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR 2007, 189:W320-W323.
25. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
26. Palmentieri B., de Sio I., La Mura V., Msarone M., Vecchione R., Bruno S., et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006, 38:485-489.
27. Celle G., Savarino V., Picciotto A., Magnolia M.R., Scalabrini P., Dodero M. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Soc 1988, 33:467-471.
28. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiographic imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
29. Hernaez R., Lazo M., Bonekamp S., Kamel I., Brancati F.L., Guallar E., et al. Diagnostic accuracy and reliability of ultrasonography in the detection of fatty liver: a meta-analysis. Hepatology 2011, 54:1082-1090.
30. Mottin C.C., Moretto M., Padoin A.V., Swarowsky A.M., Toneto M.G., Glock L., et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004, 14:635-637.
31. Perez N.E., Siddiqui F.A., Mutchnick M.G., Dhar R., Tobi M., Ullah N., et al. Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007, 41:624-629.
32. Tobari M., Hashimoto E., Yatsuji S., Torii N., Shiratori K. Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med 2009, 48:739-746.